• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂多糖对高热量饮食喂养小鼠非酒精性脂肪性肝病进展的影响

Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice.

作者信息

Matsushita N, Osaka T, Haruta I, Ueshiba H, Yanagisawa N, Omori-Miyake M, Hashimoto E, Shibata N, Tokushige K, Saito K, Tsuneda S, Yagi J

机构信息

Support Center for Women Health Care Professionals and Researchers, Tokyo Women's Medical University, Tokyo, Japan.

Department of Medicine and Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Scand J Immunol. 2016 Feb;83(2):109-18. doi: 10.1111/sji.12397.

DOI:10.1111/sji.12397
PMID:26524607
Abstract

The incidence of non-alcoholic steatohepatitis (NASH) is increasing. Because gut microbiota have been highlighted as one of the key factors in the pathogenesis of metabolic syndrome, we investigated the involvement of the bacterial component in the progression of non-alcoholic fatty liver (NAFL) to NASH. C57BL/6 mice were fed with maintenance food (MF, groups A and B) or a high caloric diet (HCD, groups C and D) for 1 month. Mice were then divided into four groups: Groups A and C were inoculated with PBS, while groups B and D were inoculated with lipopolysaccharide (LPS) plus complete Freund's adjuvant (CFA). The inoculations were performed a total of 3 times over 3 months. At 6 months, while hepatic steatosis was observed in groups C and D, cellular infiltration and fibrosis were less evident in group C than in group D. Inflammatory cytokines were upregulated in groups B and D. 16S rRNA pyrosequencing of whole colon homogenates containing faeces showed that certain bacterial groups, such as Bacteroidaceae, Peptostreptococcaceae and Erysipelotrichaceae, were increased in groups C and D. Although loading of bacterial components (LPS) resulted in hepatic inflammation in both MF- and HCD-fed mice, HCD feeding was more crucial in the progression of NAFL during the triggering phase.

摘要

非酒精性脂肪性肝炎(NASH)的发病率正在上升。由于肠道微生物群已被视为代谢综合征发病机制的关键因素之一,我们研究了细菌成分在非酒精性脂肪肝(NAFL)进展为NASH过程中的作用。将C57BL/6小鼠喂食维持食物(MF,A组和B组)或高热量饮食(HCD,C组和D组)1个月。然后将小鼠分为四组:A组和C组接种磷酸盐缓冲盐水(PBS),而B组和D组接种脂多糖(LPS)加完全弗氏佐剂(CFA)。在3个月内共进行3次接种。6个月时,虽然在C组和D组中观察到肝脏脂肪变性,但C组中的细胞浸润和纤维化比D组中更不明显。炎症细胞因子在B组和D组中上调。对含有粪便的全结肠匀浆进行16S rRNA焦磷酸测序显示,某些细菌类群,如拟杆菌科、消化链球菌科和丹毒丝菌科,在C组和D组中有所增加。尽管细菌成分(LPS)的注入在喂食MF和HCD的小鼠中均导致肝脏炎症,但在触发阶段,喂食HCD对NAFL的进展更为关键。

相似文献

1
Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice.脂多糖对高热量饮食喂养小鼠非酒精性脂肪性肝病进展的影响
Scand J Immunol. 2016 Feb;83(2):109-18. doi: 10.1111/sji.12397.
2
Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease the modulation of the gut microbiota in rabbits.原花青素 B2 通过调节兔肠道微生物群预防饮食诱导的肥胖和非酒精性脂肪肝。
World J Gastroenterol. 2019 Feb 28;25(8):955-966. doi: 10.3748/wjg.v25.i8.955.
3
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.肠道微生物群对非酒精性脂肪性肝炎发生发展的影响。
Eur J Nutr. 2018 Apr;57(3):861-876. doi: 10.1007/s00394-017-1524-x. Epub 2017 Sep 5.
4
Distinctly altered gut microbiota in the progression of liver disease.肝病进展过程中肠道微生物群明显改变。
Oncotarget. 2016 Apr 12;7(15):19355-66. doi: 10.18632/oncotarget.8466.
5
Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.肥胖小鼠饮食诱导的非酒精性脂肪性肝炎和肝纤维化的品系依赖性与糖尿病和炎症表型有关。
Liver Int. 2014 Aug;34(7):1084-93. doi: 10.1111/liv.12335. Epub 2013 Oct 25.
6
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.泛半胱天冬酶抑制剂恩瑞卡森(IDN-6556)可减轻非酒精性脂肪性肝炎小鼠模型中的肝损伤和纤维化。
Liver Int. 2015 Mar;35(3):953-66. doi: 10.1111/liv.12570. Epub 2014 Jun 6.
7
Galactomannan More than Pectin Exacerbates Liver Injury in Mice Fed with High-Fat, High-Cholesterol Diet.半乳甘露聚糖甚于果胶加剧高脂高胆固醇饮食喂养小鼠的肝损伤。
Mol Nutr Food Res. 2018 Oct;62(20):e1800331. doi: 10.1002/mnfr.201800331. Epub 2018 Aug 19.
8
Modulation of Gut Microbiota by Berberine Improves Steatohepatitis in High-Fat Diet-Fed BALB/C Mice.黄连素对肠道微生物群的调节改善了高脂饮食喂养的BALB/C小鼠的脂肪性肝炎。
Arch Iran Med. 2016 Mar;19(3):197-203.
9
Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.红车轴草提取物对蛋氨酸-胆碱缺乏饮食诱导的C57BL/6小鼠脂肪性肝炎的影响。
Chin J Nat Med. 2014 Mar;12(3):194-8. doi: 10.1016/S1875-5364(14)60032-7.
10
Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.静脉注射多能基质细胞可预防代谢综合征肥胖小鼠非酒精性脂肪性肝炎的发生。
J Hepatol. 2011 Nov;55(5):1112-20. doi: 10.1016/j.jhep.2011.02.020. Epub 2011 Feb 26.

引用本文的文献

1
A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease.新见解:中性粒细胞胞外诱捕网与肠道-肝脏轴在非酒精性脂肪性肝病中的相互作用
Front Immunol. 2025 Jun 27;16:1599956. doi: 10.3389/fimmu.2025.1599956. eCollection 2025.
2
Identification of diagnostic markers pyrodeath-related genes in non-alcoholic fatty liver disease based on machine learning and experiment validation.基于机器学习和实验验证的非酒精性脂肪性肝病 pyroptosis 相关基因诊断标志物的鉴定。
Sci Rep. 2024 Oct 26;14(1):25541. doi: 10.1038/s41598-024-77409-3.
3
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future.
益生菌对环境诱导的肝毒性的治疗作用:机制、临床前景、局限性与未来展望
Probiotics Antimicrob Proteins. 2025 Apr;17(2):516-540. doi: 10.1007/s12602-024-10365-6. Epub 2024 Sep 24.
4
Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis.非酒精性脂肪性肝病和疑似非酒精性脂肪性肝炎患者的肠道微生物群特征
J Res Med Sci. 2022 Jul 29;27:54. doi: 10.4103/jrms.jrms_673_21. eCollection 2022.
5
Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.过氧化物酶体增殖物激活受体-α 激活和二肽基肽酶-4 抑制靶向肠道菌群失调治疗肥胖小鼠的脂肪肝。
World J Gastroenterol. 2022 May 7;28(17):1814-1829. doi: 10.3748/wjg.v28.i17.1814.
6
Fecal Microbiota Transplant from Human to Mice Gives Insights into the Role of the Gut Microbiota in Non-Alcoholic Fatty Liver Disease (NAFLD).从人到小鼠的粪便微生物群移植为了解肠道微生物群在非酒精性脂肪性肝病(NAFLD)中的作用提供了线索。
Microorganisms. 2021 Jan 19;9(1):199. doi: 10.3390/microorganisms9010199.
7
Inhibition of lipopolysaccharide-induced inflammation via the protective role of T regulatory cells in the fetal liver in a late-pregnancy preterm mouse model.通过 T 调节细胞在晚期妊娠早产小鼠模型胎肝中的保护作用抑制脂多糖诱导的炎症。
Clinics (Sao Paulo). 2020 Nov 11;75:e1665. doi: 10.6061/clinics/2020/e1665. eCollection 2020.
8
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
9
Role of Gut Microbiota in Hepatocarcinogenesis.肠道微生物群在肝癌发生中的作用。
Microorganisms. 2019 May 5;7(5):121. doi: 10.3390/microorganisms7050121.
10
Gut Microbiota's Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics.肠道微生物群与肝病的关系及其在膳食天然产物和益生菌的肝保护作用中的作用。
Nutrients. 2018 Oct 8;10(10):1457. doi: 10.3390/nu10101457.